Kewaunee scientific corp /de/ (KEQU)
CashFlow / Yearly
Apr'19Apr'18Apr'17Apr'16Apr'15Apr'14Apr'13Apr'12Apr'11Apr'10
Cash flows from operating activities:
Net earnings (loss)

1,688

5,458

4,620

3,877

3,640

4,003

3,681

1,800

2,098

3,750

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation

2,571

2,761

2,702

2,592

2,615

2,549

2,653

2,664

2,487

2,348

Bad debt provision

65

344

37

74

55

116

34

214

60

163

Stock based compensation expense

197

355

199

192

-

-

-

-

-

-

Stock based compensation expense

-

-

-

-

196

238

-

-

-

-

Provision for deferred income tax expense

202

1,127

234

-335

-513

864

-

-

-

-

Stock based compensation expense

-

-

-

-

-

-

239

261

225

-

Provision for deferred income tax expense

-

-

-

-

-

-

-526

-1,539

223

-393

Change in assets and liabilities:
Increase in prepaid income taxes

-

-

-

-

-

-

-

-

-

-9

Receivables

664

3,115

2,091

-1,197

5,688

-2,295

2,674

-4,663

1,237

1,806

Inventories

-456

2,866

-691

2,881

807

-1,265

1,443

1,294

2,116

511

Accounts payable and other accrued expenses

-55

4,606

686

1,351

3,008

-2,862

2,604

-459

-672

977

Deferred revenue

-285

-3,922

5,021

569

79

-351

-874

-521

522

-712

Other, net

-1,685

-1,565

-437

635

-294

-48

133

1,134

-319

708

Net cash (used in) provided by operating activities

-

-

-

-

2,291

8,069

3,827

6,923

-

-

Net cash provided by operating activities

2,490

3,183

11,662

7,271

-

-

-

-

1,271

4,533

Cash flows from investing activities:
Capital expenditures

4,213

3,395

2,611

2,187

2,568

2,021

2,405

1,435

5,247

4,239

Decrease (increase) in restricted cash

-

-

-132

-709

1,908

-323

-13

151

9

88

Net cash used in investing activities

-

-

-

-

-4,476

-1,698

-2,392

-1,586

-

-

Net cash used in investing activities

-4,213

-3,395

-2,479

-1,478

-

-

-

-

-5,256

-4,327

Cash flows from financing activities:
Dividends paid

2,030

1,794

1,570

1,361

1,234

1,122

1,035

1,031

1,030

976

Dividends paid to noncontrolling interest in subsidiaries

51

74

56

75

38

38

744

-

-

383

Proceeds from short-term borrowings

62,646

59,069

51,407

48,706

-

-

-

-

1,716

-848

Repayments on short-term borrowings

57,018

58,775

51,634

49,843

-

-

-

-

-

-

Increase in short-term borrowings and interest rate swaps

-

-

-

-

1,805

-3,847

181

228

-

-

Payments on long-term debt and lease obligations

1,177

918

421

422

421

3,854

200

200

133

-

Proceeds from long-term debt

-

-

-

-

-

5,000

-

-

4,000

-

Payments on capital leases

-

-

-

-

-

-

36

83

82

220

Payment toward purchase of noncontrolling interest in subsidiary

-

-

-

888

888

1,780

-

-

-

-

Net proceeds from exercise of stock options

-36

8

190

479

33

92

116

-

34

-141

Net cash used in financing activities

-

-

-

-

-743

-5,549

-1,718

-1,086

-

-

Net cash used in financing activities

2,334

-2,484

-2,084

-3,404

-

-

-

-

4,505

-2,286

Effect of exchange rate changes on cash and cash equivalents

-413

-287

-

-

-

-

-

-

-

-

Increase (decrease) in cash, cash equivalents and restricted cash

198

-2,983

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

185

-211

-276

-385

-94

-465

160

243

(Decrease) increase in cash and cash equivalents

-

-

7,284

2,178

-3,204

437

-377

3,786

680

-1,837

Interest paid

-

-

-

-

323

413

374

444

174

157

Interest paid

352

295

292

306

-

-

-

-

-

-

Income taxes paid

2,460

2,872

2,618

2,387

1,873

2,585

1,722

418

1,474

1,308

Purchase of noncontrolling interest in subsidiary - Other accrued expenses and other non-current liabilities

-

-

-

-

-

1,775

-

-

-

-

Fixed assets in accounts payable

-

-

-

-

-

-

-

-

-

555